Karin Bryder has extensive experience as project manager within the fields of pharmaceuticals and med tech and has acted as IP manager and CEO of companies using a virtual company format. Karin holds a PhD in Medical Science with focus on Immunology. Her academic work also includes studies of DNA vaccines and virus genetics.Anki Malmborg has extensive experience from business development within life science. She has worked for several small biotech companies, both as CEO and board member and as an investment director. Anki has a M. Sc. in Chemical Engineering, holds a Ph.D. in Immunotechnology from Lund University and a Pharma-MBA from Falconbury.Eskil Söderlind has extensive experience from the business area with focus on life science He has past and present experience as Investment Director, CEO and as board member. Eskil´s formal education includes a PhD in molecular biology from Uppsala and an associate professorship at Lund University; he also has an executive Master of Business Administration (MBA) diploma